tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Windtree Therapeutics announces istaroxime chosen for presentation at HFSA
PremiumThe FlyWindtree Therapeutics announces istaroxime chosen for presentation at HFSA
2M ago
Windtree Therapeutics Terminates SEISMiC-C Clinical Study
Premium
Company Announcements
Windtree Therapeutics Terminates SEISMiC-C Clinical Study
2M ago
Windtree Therapeutics Reveals Promising Phase 2 Study Data
Premium
Company Announcements
Windtree Therapeutics Reveals Promising Phase 2 Study Data
2M ago
Windtree enters into common stock purchase agreement for up to $500M
PremiumThe FlyWindtree enters into common stock purchase agreement for up to $500M
2M ago
Windtree Therapeutics, Kraken announce strategic partnership
Premium
The Fly
Windtree Therapeutics, Kraken announce strategic partnership
2M ago
Windtree Therapeutics Announces $60M Securities Agreement
Premium
Company Announcements
Windtree Therapeutics Announces $60M Securities Agreement
2M ago
Windtree Therapeutics CFO Resignation and Leadership Shift
PremiumCompany AnnouncementsWindtree Therapeutics CFO Resignation and Leadership Shift
3M ago
Windtree Therapeutics Receives Nasdaq Deficiency Letter
Premium
Company Announcements
Windtree Therapeutics Receives Nasdaq Deficiency Letter
3M ago
Windtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
Premium
The Fly
Windtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100